Authorities in Saudi Arabia have registered the Pfizer-BioNTech COVID-19 vaccine for import and use in the country.
According to state news agency SPA, Saudi Arabia's Food and Drug Agency (SFDA) registered the vaccine.
Procedures necessary for its import and use will begin soon.
The SFDA will analyse samples from each incoming vaccine shipment before using it to ensure its quality.
"The decision to approve the vaccine's registration was based on the data provided by Pfizer on November 24, as soon as the requirements were completed, the Authority began reviewing and evaluating the registration files from several aspects," SPA said.
SFDA Approves Registration of Pfizer-BioNTech COVID-19 Vaccine.https://t.co/4xUze5bXBC #SPAGOV pic.twitter.com/j12AfVkzKK
— SPAENG (@Spa_Eng) December 10, 2020


US, India agree on trade deal and lower tariffs, says Trump
Israel reopens Gaza's Rafah border crossing to Egypt, with limits
US envoy Witkoff to visit Israel, meet Netanyahu, Israeli officials say
Russian drone strike kills 12 miners in Ukraine
Singapore to launch space agency in response to global investment surge
Five-year-old boy returns to Minnesota after ICE release
Reopening of Gaza's Rafah crossing expected Monday
Winter storm death toll in United States reaches 90
